TNF-Related Apoptosis-Inducing Ligand
-
Subject Areas on Research
-
A comparison of host response strategies to distinguish bacterial and viral infection.
-
A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.
-
Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.
-
Blazing a new TRAIL in hematopoietic cell transplantation.
-
Cytoprotective effects of IAPs revealed by a small molecule antagonist.
-
Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis.
-
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
-
Gene expression patterns that characterize advanced stage serous ovarian cancers.
-
Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.
-
High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival.
-
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
-
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.
-
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
-
Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
-
Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death.
-
Lipopolysaccharide-induced expression of TRAIL promotes dendritic cell differentiation.
-
Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.
-
Next-generation Tumor-homing Induced Neural Stem Cells as an Adjuvant to Radiation for the Treatment of Metastatic Lung Cancer.
-
Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
-
On the TRAIL from p53 to apoptosis?
-
PPARgamma agonists follow an unknown TRAIL in lung cancer.
-
Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death.
-
Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis.
-
Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.
-
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.
-
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
-
The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
-
The p35 relative, p49, inhibits mammalian and Drosophila caspases including DRONC and protects against apoptosis.
-
The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3.
-
Three-in-one chromatography-free purification, tag removal, and site-specific modification of recombinant fusion proteins using sortase A and elastin-like polypeptides.
-
X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells.
-
XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.
-
c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis.
-
Keywords of People